These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31649844)

  • 1. Synergistic antitumor activity of artesunate and HDAC inhibitors through elevating heme synthesis
    Chen CP; Chen K; Feng Z; Wen X; Sun H
    Acta Pharm Sin B; 2019 Sep; 9(5):937-951. PubMed ID: 31649844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Isoniazid Metabolites Hydrazine and Pyridoxal Isonicotinoyl Hydrazone Modulate Heme Biosynthesis.
    Brewer CT; Yang L; Edwards A; Lu Y; Low J; Wu J; Lee RE; Chen T
    Toxicol Sci; 2019 Mar; 168(1):209-224. PubMed ID: 30517741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.
    Peoc'h K; Nicolas G; Schmitt C; Mirmiran A; Daher R; Lefebvre T; Gouya L; Karim Z; Puy H
    Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma.
    Lanzi C; Favini E; Dal Bo L; Tortoreto M; Arrighetti N; Zaffaroni N; Cassinelli G
    J Exp Clin Cancer Res; 2021 Dec; 40(1):381. PubMed ID: 34857011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.
    LaBonte MJ; Wilson PM; Fazzone W; Groshen S; Lenz HJ; Ladner RD
    BMC Med Genomics; 2009 Nov; 2():67. PubMed ID: 19948057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis of delta-aminolevulinic acid and the regulation of heme formation by immature erythroid cells in man.
    Gardner LC; Smith SJ; Cox TM
    J Biol Chem; 1991 Nov; 266(32):22010-8. PubMed ID: 1939222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ubiquitous mitochondrial protein unfoldase CLPX regulates erythroid heme synthesis by control of iron utilization and heme synthesis enzyme activation and turnover.
    Rondelli CM; Perfetto M; Danoff A; Bergonia H; Gillis S; O'Neill L; Jackson L; Nicolas G; Puy H; West R; Phillips JD; Yien YY
    J Biol Chem; 2021 Aug; 297(2):100972. PubMed ID: 34280433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy.
    Yang X; Li W; Palasuberniam P; Myers KA; Wang C; Chen B
    Photochem Photobiol; 2015; 91(4):923-30. PubMed ID: 25809721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex response to physiological and drug-induced hepatic heme demand in monoallelic
    Vagany V; Robinson S; Chernova T; Smith AG
    Mol Genet Metab Rep; 2021 Dec; 29():100818. PubMed ID: 34900592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation and proteomic changes on the heme pathway following treatment with 5-aminolevulinic acid.
    Sansaloni-Pastor S; Varesio E; Lange N
    J Photochem Photobiol B; 2022 Aug; 233():112484. PubMed ID: 35671620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines.
    Bandolik JJ; Hamacher A; Schrenk C; Weishaupt R; Kassack MU
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitors enhance the anticancer activity of nutlin-3 and induce p53 hyperacetylation and downregulation of MDM2 and MDM4 gene expression.
    Palani CD; Beck JF; Sonnemann J
    Invest New Drugs; 2012 Feb; 30(1):25-36. PubMed ID: 20680659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterozygous disruption of ALAS1 in mice causes an accelerated age-dependent reduction in free heme, but not total heme, in skeletal muscle and liver.
    van Wijk K; Akabane T; Kimura T; Saitoh S; Okano S; Kelly VP; Takagi M; Kodama K; Takahashi K; Tanaka T; Nakajima M; Nakajima O
    Arch Biochem Biophys; 2021 Jan; 697():108721. PubMed ID: 33307066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
    Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
    Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells.
    Berghauser Pont LM; Kleijn A; Kloezeman JJ; van den Bossche W; Kaufmann JK; de Vrij J; Leenstra S; Dirven CM; Lamfers ML
    PLoS One; 2015; 10(5):e0127058. PubMed ID: 25993039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells.
    Dejligbjerg M; Grauslund M; Litman T; Collins L; Qian X; Jeffers M; Lichenstein H; Jensen PB; Sehested M
    Mol Cancer; 2008 Sep; 7():70. PubMed ID: 18789133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular docking of curcumin and curcuminoids as human Zn
    Anandaradje A; Kalita B; Coumar MS; Selvarajan S
    In Silico Pharmacol; 2024; 12(1):47. PubMed ID: 38817777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vorinostat Treatment of Gastric Cancer Cells Leads to ROS-Induced Cell Inhibition and a Complex Pattern of Molecular Alterations in Nrf2-Dependent Genes.
    Lorenz L; Zenz T; Oliinyk D; Meier-Rosar F; Jenke R; Aigner A; Büch T
    Pharmaceuticals (Basel); 2024 Aug; 17(8):. PubMed ID: 39204185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulators.
    Beider K; Bitner H; Voevoda-Dimenshtein V; Rosenberg E; Sirovsky Y; Magen H; Canaani J; Ostrovsky O; Shilo N; Shimoni A; Abraham M; Weiss L; Milyavsky M; Peled A; Nagler A
    Biochem Pharmacol; 2019 Oct; 168():412-428. PubMed ID: 31325448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothesis: Metabolic targeting of 5-aminolevulinate synthase by tryptophan and inhibitors of heme utilisation by tryptophan 2,3-dioxygenase as potential therapies of acute hepatic porphyrias.
    Badawy AA
    Med Hypotheses; 2019 Oct; 131():109314. PubMed ID: 31443750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.